Talk:Merck & Co.

by chance I had to research changes in the field of coxibes to which the recently withdrawn pain killer and blockbuster VIOXX of Merck belongs.

According to http://news.findlaw.com/ap_stories/f/1310/11-22-2004/20041122043002_20.html Merck's chairman said: "We are confident that a careful and complete examination of Merck's conduct shows that, at all times, we acted responsibly and in a manner consistent with Merck's commitment to patient safety and to our rigorous adherence to scientific investigation, openness and integrity."

I do not know if this is disinformation, but would like to post here two articles which might show problems worth to be discussed and regarded:

1. http://www.biomedcentral.com/news/20040123/03.htm reports on January 23, 2004 under the title:

"Scientist, drug firm in court Spanish lawsuit over a report in a newsletter raises concerns about freedom of scientific debate | By Xavier Bosch

that "questions of scientific freedom of expression have been raised in Spain" when the spanish MERCK company, Merck Sharp and Dohme (MSD)brought a court case  against Juan Ramón Laporte, a renowned Spanish pharmacologist at the Autonomous University of Barcelona.

The case began on January 16 in Madrid and relates to an article "in which the scientist commented on irregularities surrounding clinical trials of COX-2 inhibitors. "